Objectives: Coronary artery revascularization with cardiopulmonary bypass (ONCAB) has been reported to carry several risks for patients with poor left ventricular (LV) function (ejection fraction -30%). Off-pump CABG (OPCAB) has been proposed to result in a better outcome, but mid-and long-term survival rates have never been compared. The aim of this study is to assess the effect of cardiopulmonary bypass on this group of patients. Methods: In a 10-year period, a total of 934 patients with poor LV function undergoing isolated first-time coronary artery bypass graft were studied. They were divided into two groups, the ONCAB group, with 528 patients, and the OPCAB group with 406 patients. The EuroSCORE was significantly higher in the OPCAB group (Ps0.049). After adjusting for the preoperative characteristics, postoperative complications, in-hospital mortality, mid-term survival rate (five years), and long-term survival rate (10 years) were compared. Results: The average number of grafts was 3.7 in the ONCAB group and 3.1 in the OPCAB group (P-0.001). Postoperative complications of ONCAB and OPCAB groups such as; atrial fibrillation (29.6% vs. 28.6%), renal failure (9.3% vs. 9.6%), stroke (2.3% vs. 0.7%), and perioperative myocardial infarction (MI) (3.8% vs. 2.0%), were comparable between groups. Length of intensive care unit stay, hospital stay and ventilation time were considerably shorter in the OPCAB group (P-0.05). The incidence of wound infection was also lower in the OPCAB patients (P-0.05). After adjusting for the preoperative characteristics the incidence of most postoperative complications remained the same between the two groups, except for MI, which was lower in the OPCABs (P-0.04). Despite a lower number of proximal anastomoses in the OPCAB patients, the rate of stroke remained the same between the OPCAB and ONCAB patients (0.09% vs. 1.6%). Inhospital mortality was higher in ONCAB compared to OPCAB (7.8% vs. 5.7%), but this difference did not reach statistical significance (Ps0.21). Likewise, mid-term and long-term survival rates were similar even with matched preoperative characteristics. However, reintervention rate was found to be higher in the OPCABs (P-0.001). Conclusions: Despite the reported benefits of OPCAB, there was no significant influence on the in-hospital mortality, mid-term survival or long-term survival in patients with LV dysfunction. With adequate myocardial protection in ONCAB and complete revascularization in OPCAB, similar results are achievable.
Introduction
Coronary artery bypass graft (CABG) with cardiopulmonary bypass (ONCAB) has been reported to carry several risks for patients with poor left ventricular (LV) function. Cardiopulmonary bypass (CPB) results in the activation of inflammatory mediators w1x exacerbating myocardial damage in impaired ventricles. In addition, other factors are known to contribute to myocardial injury postCPB, such as direct damage to myocardial cells during manipulation and cannulation, effect of potassium and hypothermia or fibrillation on cellular function and cell membrane, and alteration of coronary blood flow w2x. It is also reported that ONCAB results in more pronounced endothelial dysfunction and impairment of vasodilatation w3x.
Even in uncomplicated procedures, biventricular dysfunction occurs immediately after revascularization, which may be persistent after 24 h w4x. It is believed that preoperative ejection fraction (EF) and the degree of dyssynergy are the two predictors of postoperative ventricular dysfunction w4x.
Poor ventricular function is also considered an independent predictor of mortality postCABG w5, 6x. It is also assumed that the global ischaemia and myocardial stunning in ONCAB compared to regional ischaemia induced during off-pump CABG (OPCAB), can further increase myocardial injury and worsening function of a poor ventricle w7x. Moreover, segmental wall motion has been found to be better preserved during OPCAB compared to ONCAB w4, 8x, as cardioplegic arrest may induce physiological derangement of the heart w9x. These can lead to low cardiac output and increased use of inotropic requirement after ONCAB in patients with poor ventricular function w2x. Therefore, it has been proposed that OPCAB compared to ONCAB, especially in impaired ventricular function, has better outcome w10x.
In this study, we compared the early, mid-and long-term survival rates of ONCAB vs. OPCAB in patients with poor ventricular function, with the aim to assess the effect of CPB on the outcome in this group of patients.
Methods

Patient population
In this retrospective study, we reviewed prospectively collected patient data for our institution during a 10-year period from October 1998 to March 2009. Patients that underwent CABG only and had EF F30% were included. Cases that were converted from OPCAB to ONCAB intraoperatively were excluded (ns9). A total of 934 patients were included; ONCAB (ns528) and OPCAB (ns406). The choice of procedure was at the discretion of the operating surgeon. Patient details, registry database, medical records and national death index were reviewed for both groups.
Patient characteristics are summarized in Table 1 . Mean age was 66.1 (60.3-71.7) years and 67.0 (60.5-73.7) years in ONCAB and OPCAB groups, respectively. Logistic Euro-SCORE was significantly higher in the OPCAB group compared to the ONCAB (Ps0.049). However, the number of diseased coronary arteries was higher in the ONCAB compared to the OPCAB (Ps0.001).
Operation
A mixture of ONCAByOPCAB is performed in our department; four surgeons are OPCAB surgeons, five are ONCAB surgeons and one surgeon has a mixed practice. The selection of the procedure was based on each surgeons practice.
In both ONCAB and OPCAB groups, heparin was given at a dose of 300 Uykg. In the ONCAB group, the ascending aorta was cannulated for inflow and a two stage venous cannula to the right atrium was used for venous drainage. Nonpulsatile flow was used with a flow rate of 2.4 l/m /min 2 and temperature was kept between 32 8C and 34 8C. We used myocardial protection with anterograde blood cardioplegia in all the cases. In addition, a retrograde cannula was inserted in some cases (ns94) depending on the operating surgeon.
In the OPCAB group, an Octopus tissue stabilizer (Medtronic, Minneapolis, MN, USA) was used. After exposing the anastomotic site on the target vessels, an intra-coronary shunt was used and coronary anastomosis was performed.
Statistics
Continuous variables not normally distributed are shown as median with 25th and 75th percentiles. Categorical data are shown as percentages. Univariate comparisons were made with Wilcoxon rank sum tests and x -tests as appro-2 priate. Deaths occurring over time were described using Kaplan-Meier survival curves w11x.
To account for differences in case mix we developed a propensity score for ventricular dysfunction group membership w12x. The propensity for ventricular dysfunction group membership was determined without regard to outcome, using multivariable logistic regression analysis w13x. A full non-parsimonious model was developed that included all variables listed in Table 1 . The goal is to balance patient characteristics by incorporating everything recorded that may relate to either systematic bias or simply bad luck. This model yielded a C-statistic of 0.71, indicating an acceptable ability to differentiate between patients with or without ventricular dysfunction. We then used a macro (available at: http:yywww2.sas.comyproceedingsysugi29y 165-29.pdf) to perform propensity-matching.
In all cases a P-value -0.05 was considered significant. All statistical analysis was performed retrospectively using SAS for Windows Version 8.2.
Results
Operation
Non-elective cases comprised 26.9% of all cases in the ONCAB group and 28.1% in the OPCAB group (Ps0.69). The ONCAB, on-pump coronary artery bypass; OPCAB, off-pump coronary artery bypass; IABP, intra-aortic balloon pump; CK-MB, creatine kinase-myocardial band; ICU, intensive care unit; LOS, length of stay; PCI, percutaneous intervention; CABG, coronary artery bypass graft; ITU, intensive treatment unit. median number of distal anastomoses performed was four in the ONCAB and three in the OPCAB (P-0.001). Inotropic support was required in 68.6% of the ONCAB group, compared to 38.7% in the OPCAB group (P-0.001). The use of postoperative intra-aortic balloon pump (IABP) was 10.6% in the ONCAB and 7.9% in the OPCAB with insignificant statistical difference (Ps0.16). Furthermore, the rate of re-exploration for bleeding was similar between the two groups (Ps0.53), and similar postoperative blood loss through the mediastinal and pleural drains were observed (Ps0.13). However, the average ventilation time, length of intensive care unit (ICU) stay, as well as hospital stay were significantly higher in the ONCAB patients compared to OPCAB (P-0.05, Table 2 ).
After adjusting for the preoperative characteristics, postoperative inotropic requirement, ventilation time and length of ICU stay remained significantly higher in the ONCAB patients compared to the OPCAB (P-0.05, Table 2 ).
Postoperative complications
Most postoperative complications were similar between the two groups apart for surgical wound infection, which was observed to be higher in the ONCAB group (Ps0.03). Despite a higher stroke rate (2.3%) in the ONCAB group compared to the OPCAB (0.7%), the difference did not reach statistical significance (Ps0.06). However, after further analysing patients with postoperative stroke, it was noted that there was a statistically significant difference in the number of proximal anastomoses to the aorta between ONCAB and OPCAB groups (Ps0.03, Table 2 ). This was due to the preferred technique adopted by most of the OPCAB surgeons using total arterial grafts or sequential grafts to avoid the manipulation of the aorta.
After adjusting for the preoperative characteristics, the risk of surgical wound infection lost significance but the perioperative myocardial infarction (MI) rate achieved significance and this was supported by a statistically higher postoperative creatine kinase-myocardial band (CK-MB, Table 2 ).
In-hospital mortality
In-hospital mortality was higher in the ONCAB compared to that of OPCAB (7.8% vs. 5.7%), but this difference was not statistically significant (Ps0.21), even after adjusting for the preoperative patient characteristics and co-morbidities (Ps0.06).
Short-, mid-and long-term survival rate
Short-, mid-and long-term survival rates were found to be similar before and after matching for the preoperative characteristics ( Fig. 1 and Table 3 ). Despite the higher number of cases receiving total arterial grafts in the OPCAB group, their survival rate was not different from those in the ONCAB group.
Re-intervention
In a 10-year follow-up, re-intervention with percutaneous coronary intervention (PCI) was found to be significantly higher in the OPCAB compared to the ONCAB, before and after adjusting for the preoperative characteristics (P-0.001). However, no patient required redo-CABG in a 10-year period ( Table 2) .
Discussion
It has been previously reported that coronary artery revascularization provides a better prognosis compared with medical therapy in patients with LV dysfunction w14x. Furthermore, with the growing number of patients with impaired ventricular function requiring coronary artery revascularization, the best method of myocardial protection is a matter of debate. Studies have shown that apart from cardioplegic arrest, other techniques of myocardial protection, such as hypothermic ventricular fibrillation, with or without aortic cross-clamping, are feasible in patients with poor LV function w8x. However, the risks and benefits of using CPB in this subgroup of patients have not been clearly established.
The systemic inflammatory response resulting from CPB is believed to contribute to some of the complications after ONCAB w15x. Therefore, avoiding CPB potentially offers a safer alternative especially in an impaired ventricle w16x. Previous reports comparing ONCAB to the OPCAB have shown mixed results. Meharwal et al. showed good results with OPCAB in high-risk patients and in LV dysfunction.
However, in his report no controls were included for comparison w17x. Al-Ruzzeh et al. observed the same rate of inhospital mortality with ONCAB and OPCAB patients and concluded that the OPCAB group, which included a significantly higher proportion of older patients with poor ventricular function, afford evident benefits w18, 19x. However, in his report no risk adjustment or matching was performed and therefore this lack of more 'direct' comparison negates any observed benefits of OPCAB. After risk adjustment for preoperative characteristics, Dewey et al. reported improved outcome with OPCAB w20x. Despite, reports of better outcome and fewer postoperative complications in the OPCAB patients compared to those of ONCAB especially in the high-risk subgroups w10, 21x, we did not observe any differences postoperatively. Although both in-hospital mortality and stroke rate were less in the OPCAB group, this difference failed to achieve statistical significance.
Similar studies comparing matched groups also showed no statistical difference in postoperative complications, inhospital mortality, early and mid-term survival rates between ONCAB and OPCAB in patients with poor LV function w22, 23x. The total number of cases in each of these studies was around 200 patients only and to our knowledge our study is the first to compare the long-term survival rate between ONCAB and OPCAB in over 900 patients.
The main limitation of our study is its retrospective nature and the lack of randomization. Due to the high risk nature of coronary artery revascularization in patients with poor ventricular function, no prospective randomized trials comparing ONCAB and OPCAB in this category of patient has been or is likely to be conducted. However, the propensity score analysis and risk adjustment for the preoperative characteristics have minimized the selection and comparison bias between the ONCAB and OPCAB groups.
In summary, our study failed to show any differences with or without CPB in the operative complications, in-hospital mortality, and short-, mid-and long-term survival rate in patients with poor LV function. We believe OPCAB is a safe alternative to ONCAB but we have not demonstrated its superiority to ONCAB, although there was a tendency for a lesser incidence for perioperative stroke, MI and early mortality.
